Thomas D. Nolin
Affiliations: | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Pharmacy, Cell Biology, Molecular BiologyGoogle:
"Thomas Nolin"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Butrovich MA, Reaves AC, Heyward J, et al. (2023) Inclusion of Participants with Chronic Kidney Disease and Other Kidney-Related Considerations during Clinical Drug Development. Clinical Journal of the American Society of Nephrology : Cjasn |
| Franchetti Y, Nolin TD. (2021) Dose Optimization in Kidney Disease: Opportunities for PBPK Modeling and Simulation. Journal of Clinical Pharmacology. S36-S51 |
| Perazella MA, Nolin TD. (2020) Adverse Drug Effects in Patients with CKD: Primum Non Nocere. Clinical Journal of the American Society of Nephrology. 15: 1075-1077 |
| Jawale CV, Ramani K, Li DD, et al. (2020) Restoring glucose uptake rescues neutrophil dysfunction and protects against systemic fungal infection in mouse models of kidney disease. Science Translational Medicine. 12 |
| Kimber C, Zhang S, Johnson C, et al. (2020) Randomized, Placebo-controlled Trial of Rifaximin Therapy for Lowering Gut-derived Cardiovascular Toxins and Inflammation in Chronic Kidney Disease Kidney |
| Prokopienko AJ, West RE, Schrum DP, et al. (2019) Metabolic Activation of Flavin Monooxygenase-mediated Trimethylamine-N-Oxide Formation in Experimental Kidney Disease. Scientific Reports. 9: 15901 |
| Prokopienko AJ, West RE, Stubbs JR, et al. (2019) Development and validation of a UHPLC-MS/MS method for measurement of a gut-derived uremic toxin panel in human serum: An application in patients with kidney disease. Journal of Pharmaceutical and Biomedical Analysis. 174: 618-624 |
| Casal MA, Nolin TD, Beumer JH. (2019) Estimation of Kidney Function in Oncology: Implications for Anticancer Drug Selection and Dosing. Clinical Journal of the American Society of Nephrology. 14: 587-595 |
| Stubbs JR, Stedman MR, Liu S, et al. (2019) Trimethylamine -Oxide and Cardiovascular Outcomes in Patients with End-stage Kidney Disease Receiving Maintenance Hemodialysis. Clinical Journal of the American Society of Nephrology : Cjasn |
| Tan ML, Zhao P, Zhang L, et al. (2018) Use of physiologically-based pharmacokinetic (PBPK) modeling to evaluate the effect of chronic kidney disease on the disposition of hepatic CYP2C8 and OATP1B drug substrates. Clinical Pharmacology and Therapeutics |